Clinical Trial Update: Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sorafenib with erlotinib or sorafenib alone in advanced non-small cell lung cancer progressing on erlotinib, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Tarceva (erlotinib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-02